No Data
Peering Into Novavax's Recent Short Interest
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $22
Novavax's Strategic Partnerships and Pipeline Developments Drive Buy Rating With Promising Long-term Growth Potential
Novavax Says Australia Cancels Delivery of Some Covid-19 Doses
Express News | Novavax- Agreed to Updated Delivery Schedule for Potential Delivery of Covid-19 Vaccine/Future Variant Covid-19 Vaccine Through End of 2029
Express News | Novavax- Acknowledged Commonwealth Cancellation of Delivering Certain Doses of Co’s Covid-19 Vaccine Scheduled for Delivery Between Q4 2023 & Q4 2025
No Data
Krystian 1983 : This is on the Way to explode
200
